James Sidoti
Stock Analyst at Sidoti & Co.
(3.02)
# 1,459
Out of 5,042 analysts
9
Total ratings
60%
Success rate
71.66%
Average return
Main Sectors:
Stocks Rated by James Sidoti
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Neutral | $27 → $28 | $26.27 | +6.59% | 3 | Aug 5, 2025 | |
| SRDX Surmodics | Downgrades: Neutral | $43 | $27.26 | +57.74% | 1 | May 29, 2024 | |
| CODX Co-Diagnostics | Downgrades: Neutral | $5 | $0.35 | +1,325.72% | 1 | Aug 12, 2022 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $38 → $34 | $89.21 | -61.89% | 2 | Apr 8, 2020 | |
| ANIK Anika Therapeutics | Upgrades: Buy | $61 | $10.01 | +509.39% | 2 | Jan 21, 2020 |
STAAR Surgical Company
Aug 5, 2025
Downgrades: Neutral
Price Target: $27 → $28
Current: $26.27
Upside: +6.59%
Surmodics
May 29, 2024
Downgrades: Neutral
Price Target: $43
Current: $27.26
Upside: +57.74%
Co-Diagnostics
Aug 12, 2022
Downgrades: Neutral
Price Target: $5
Current: $0.35
Upside: +1,325.72%
LeMaitre Vascular
Apr 8, 2020
Maintains: Buy
Price Target: $38 → $34
Current: $89.21
Upside: -61.89%
Anika Therapeutics
Jan 21, 2020
Upgrades: Buy
Price Target: $61
Current: $10.01
Upside: +509.39%